10-Jul-2009 | research and development
Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
Funxional Therapeutics Ltd has announced the successful completion of the first Phase I study with FX125L, an orally available small molecule which belongs ...